Swiss Re is close to launching a fourth extreme mortality bond in its Vita series, spurred by a deepening of the H1N1 swine flu pandemic, Trading Risk understands.
Swiss Re is close to launching a fourth extreme mortality bond in its Vita series, spurred by a deepening of the H1N1 swine flu pandemic, Trading Risk understands.